Using genetics to gauge colorectal cancer risk
Tuesday, 20 November 2018
Colorectal cancer is among the most common of cancers. This year alone, it has claimed nearly 880 800 lives and over 1.85 million new cases have been reported around the world.
The COST Action 'Cooperation Studies on Inherited Susceptibility to Colorectal Cancer' furthered understanding of how people's genes impact their chances of developing the potentially fatal disease.
The research tapped into sample population studies in 23 countries, which included more than 50 000 patients with colorectal cancer and 50 000 who were free of the illness. It identified additional genetic variants linked to disease risk, as well as new hereditary genes - findings that could help improve screening and save lives.